- Affimed (AFMD, Financial) faces potential Nasdaq delisting due to low share price.
- Analysts project a significant upside with average target prices far exceeding current levels.
- Despite positive analyst sentiment, GuruFocus estimates suggest potential downside based on GF Value metrics.
Affimed NV (AFMD) has received a cautionary notice from Nasdaq as its stock has remained below the crucial $1.00 minimum bid price for a continuous span of 30 business days. This puts the company at risk of being delisted. Affimed has been granted a period until October 13, 2025, to rectify this compliance issue.
Wall Street Analysts' Projections
Wall Street analysts have shared their insights with bold predictions for Affimed NV. According to the one-year price targets provided by four analysts, the average target price for Affimed NV (AFMD, Financial) is positioned at $11.97. Within these projections, the high estimate reaches $24.94, while the low estimate sits at $4.99. This average target price indicates a remarkable potential upside of 1,532.32% from the current share price of $0.73, offering a glimpse of significant investment opportunity. For further insights, detailed estimate data can be accessed on the Affimed NV (AFMD) Forecast page.
The investment community seems optimistic overall, with a consensus recommendation from four brokerage firms rating Affimed NV (AFMD, Financial) at 1.8. This suggests an "Outperform" status against the firm, with the rating system spanning from 1, representing a "Strong Buy," to 5, indicating a "Sell" recommendation.
Evaluating Affimed's GF Value
In contrast to the optimistic outlook of analysts, the GF Value estimate by GuruFocus casts caution on Affimed NV (AFMD, Financial)'s potential market positioning. This proprietary metric estimates the fair market value of the stock at $0.37 in one year, suggesting a possible downside of 49.56% from the current price of $0.7335. The GF Value calculation derives from historical trading multiples, the company’s past business trajectory, and forecasted performance. For a deeper dive, more detailed data is available on the Affimed NV (AFMD) Summary page.
